Hereditary cutaneous melanoma

Seminars in Cancer Biology

Volumn 10, Issue 4, 2000, Pages 319-326

  Platz, Anton ^a   Ringborg, Ulrik ^a   Hansson, Johan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CDK4; CDKN2A; Cutaneous melanoma; Germline mutations; Hereditary melanoma

Indexed keywords

CYCLIN DEPENDENT KINASE; TUMOR PROTEIN;

CANCER CYTODIAGNOSIS; CANCER GENETICS; CHROMOSOME 1P; CHROMOSOME 9P; GENE LOCATION; GENETIC DISORDER; GENETIC LINKAGE; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA; REVIEW; SKIN TUMOR;

EID: 0033824425     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.2000.0149     Document Type: Article

References (73)

1. The hereditary variant of malignant melanoma
2. Case of fungoid disease
3. Norris
4. A pioneer in the study of melanoma
5. Origin of familial malignant melanoma from heritable melanocytic lesions: The B-K-mole syndrome
6. Precursor nevi in cutaneous malignant melanoma: A proposed nomenclature
7. Familial atypical multiple mole melanoma (FAMMM) syndrome: Segregation analysis
8. Family studies in melanoma: Identification of the atypical mole syndrome (AMS) phenotype
9. Dysplastic nevi and cutaneous melanoma risk
10. Clinical aspects of hereditary melanoma in Australia
11. Familial cutaneous malignant melanoma: Autosomal dominant trait possibly linked to the Rh locus
12. High risk of malignant melanoma in melanomaprone families with dysplastic nevi
13. Risk of melanoma and other cancers in melanoma-prone families
14. Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer
15. Xeroderma pigmentosum - Cutaneous, ocular and neurologic abnormalities in 830 published cases
16. Xeroderma pigmentosum and related disorders: Examining the linkage between defective DNA repair and cancer
17. Genetics of melanoma
18. Molecular genetics of human malignant melanoma
19. Cytogenetics of 158 patients with regional or disseminated melanoma. Subset analysis of near-diploid and simple karyotypes
20. Loss of polymorphic restriction fragments in malignant melanoma: Implications for tumor heterogeneity
21. Homozygous deletions within human chromosome band 9p21 in melanoma
22. Chromosome 9p and hereditary cutaneous malignant melanoma
23. A genetic linkage map of 27 loci from PND to FY on the short arm of human chromosome I
24. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p
25. Exclusion of the dysplastic nevus syndrome (DNS) locus from the short arm of chromosome 1 by linkage studies in Dutch families
26. Evidence against the reported linkage of the cutaneous melanomadysplastic nevus syndrome locus to chromosome Ip36
27. Locus for susceptibility to melanoma on chromosome 1p
28. Hereditary melanoma in Australia. Variable association with dysplastic nevi and absence of genetic linkage to chromosome 1p
29. Exclusion of the familial melanoma locus (MLM) from the PND/D1S47 and MYCL1 regions of chromosome arm 1p in 7 Australian pedigrees
30. Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity
31. Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity
32. Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi
33. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22
34. Confirmation of chromosome 9p linkage in familial melanoma
35. Linkage analysis in Dutch familial atypical multiple mole-melanoma (FAMMM) syndrome families. Effect of naevus count
36. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
37. A cell cycle regulator potentially involved in genesis of many tumor types
38. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
39. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest
40. A novel p16INK4A transcript
41. Complex structure and regulation of the p16 (MTS1) locus
42. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
43. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumour suppression pathways
44. Germline p16 mutations in familial melanoma
45. CDKN2A variants in a population-based sample of Queensland families with melanoma
46. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
47. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds
48. Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds
49. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group
50. Analysis of the p16 gene CDKN2, in 17 Australian melanoma kindreds
51. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma
52. Novel germline p16 mutation in familial malignant melanoma in southern Sweden
53. Prevalance of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: Analysis of a clinic-based population
54. Germline mutations of the CDKN2 gene in UK melanoma families
55. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma
56. CDKN2a/p16(INK4a) mutations and lack of p19(ARF) involvement in familial melanoma kindreds
57. CDKN2A germline mutations in UK patients with familial melanoma and multiple primary melanomas
58. Screening for tumour suppressor p16 (CDKN2A) germline mutations in Israeli melanoma families
59. Heterogeneity of melanoma risk in families of melanoma patients
60. Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma
61. Systemic cancer and the FAMMM syndrome
62. Excess cancer mortality in six Dutch pedigrees with the familial atypical multiple mole-melanoma syndrome from 1830 to 1994
63. The CDKN2A (p16) gene and human cancer
64. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
65. Increased risk of pancreatic cancer in melanoma-prone kindreds with p1tINK4 mutations
66. Brief report: A familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene
67. Familial melanoma and pancreatic cancer. Ligurian Skin Tumor Study Group
68. Familial tumor syndrome associated with a germline nonfunctional p16INK4a allele
69. Inherited susceptibility to several cancers butabsence of linkage between dysplastic nevus syndrome and CDKN2A in a melanoma family with a mutation in the CDKN2A (p16INK4A) gene
70. CDKN2A mutations in multiple primary melanomas
71. Screening of germline mutations in the CDK4, CKDN2C and TP53 genes in familial melanoma: A clinic-based population study
72. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human, melanoma
73. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma